A Brazilian team at FAPESP-supported CRID identified the strategy used by immune cells to combat the pathogen Mayaro virus, which causes symptoms similar to those of chikungunya fever. These results pave the way for the development of drugs.
A microRNA inhibitor identified by researchers at the Human Genome and Stem Cell Research Center reduced the sizes of aggressive tumors and improved survival in mice.
Patient with advanced refractory lymphoma was treated in Brazil by researchers at a center funded by FAPESP. The technique known as CAR T-cell therapy was used for first time ever in Latin America.
A project at RIDC CeMEAI aims to detect and predict flooding using images and thus automate the process of flood identification without human intervention (photo: UN Photo / Ilyas Ahmed)
Two positions are offered at a RIDC BRAINN project involving neuroimaging techniques and new machine learning approaches with the purpose of enhancing epilepsy’s diagnosis, prognosis, and treatment.
Phylogenomic analysis shows that pathogen isolated in Brazilian hospital does not belong to the genus Leishmania. Researchers at the Center for Research on Inflammatory Diseases are investigating whether this species alone can cause severe disease or intensifies symptoms in co-infected patients.
A study by researchers at the Center for Cell-Based Therapy identified microRNAs involved in pluripotency maintenance and cell differentiation. The discovery paves the way to the development of drugs capable of making ESCs regress to the earliest stage of development.